Stock Movers: Vanda Pharma FDA Approval, Nike Insider Buying, and 2025 Market Review

Vanda Pharmaceuticals FDA Approval

• 💊 Vanda Pharmaceuticals (VNDA) shares surged following the FDA approval of Nereus (tradipitant) for motion sickness-induced vomiting.
• 🚀 This marks the first treatment cleared for the condition in over 40 years, with Vanda planning a launch in the coming months.

Nike's Stock Movement

• 📈 Nike (NKE) shares saw an increase after CEO Elliot Hill disclosed a purchase of approximately $1 million in shares.
• 💡 This insider buying signals confidence, following a previous rally after Apple CEO Tim Cook's significant Nike share purchase.
• ⚠️ Despite positive insider activity, Nike had previously warned of sales declines due to weakness in China and the Converse brand.

2025 Market Performance and Trends

• 📊 The S&P 500 is projected to end 2025 up over 17%, driven by a continuing bull market fueled by artificial intelligence enthusiasm.
• 💻 The AI trade broadened beyond chip stocks to include companies involved in building data centers.
• 📈 Top performers in the S&P 500 included memory and data storage companies like SanDisk, Western Digital, Micron Technology, and Seagate Technology.
• 📉 Conversely, retailers such as Deckers Outdoor and Lululemon Athletica were among the worst performers, impacted by economic uncertainty and tariffs.

Warner Brothers and Paramount Bids

• 🎬 Warner Brothers is reportedly planning to reject Paramount's takeover bid again due to Paramount's failure to increase its offer, which WB deems inferior to Netflix's bid.
• 💰 Paramount has made multiple public offers, including a $30 per share cash bid and subsequent amendments, with assurances of significant equity financing from Larry Ellison.